|
|
|
Insider
Information: |
Foletta Mark G |
Relationship: |
EVP & Chief Financial ... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
110,179 |
|
Indirect Shares
|
62,398 |
|
|
Direct
Value |
$1,126,816 |
|
|
Indirect Value
|
$7,964,481 |
|
|
Total
Shares |
172,577 |
|
|
Total
Value |
$9,091,297 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
1
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
Percentage
Gain/Loss : |
0.7%
|
13.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Chief Financial O... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
DexCom Inc |
DXCM |
Director |
2024-05-22 |
2,973 |
2024-05-22 |
62,398 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2017-12-04 |
81,910 |
2015-08-13 |
0 |
Premium* |
|
AMN Healthcare Services Inc |
AHS |
Director |
2024-04-19 |
10,254 |
2016-04-20 |
0 |
Premium* |
|
Forte Biosciences Inc |
FBRX |
EVP & Chief Financial ... |
2019-05-28 |
15,042 |
2017-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
144 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2005-03-31 |
4 |
OE |
$5.73 |
$12,577 |
D/D |
2,195 |
22,704 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Financial OfficerSV |
|
2012-07-25 |
4 |
A |
$14.62 |
$12,866 |
D/D |
880 |
73,370 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2007-01-31 |
4 |
A |
$36.07 |
$15,005 |
D/D |
416 |
23,010 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2006-01-31 |
4 |
A |
$19.46 |
$16,103 |
D/D |
550 |
27,048 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2004-10-29 |
4 |
OE |
$5.73 |
$17,190 |
D/D |
3,000 |
22,262 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2004-11-30 |
4 |
OE |
$5.73 |
$17,190 |
D/D |
3,000 |
22,262 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2004-12-31 |
4 |
OE |
$5.73 |
$17,190 |
D/D |
3,000 |
22,262 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2005-10-17 |
4 |
OE |
$5.73 |
$19,098 |
D/D |
3,333 |
29,831 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2005-11-15 |
4 |
OE |
$5.73 |
$19,098 |
D/D |
3,333 |
29,831 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
|
2005-12-15 |
4 |
OE |
$5.73 |
$19,098 |
D/D |
3,333 |
29,831 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2006-04-17 |
4 |
OE |
$9.63 |
$19,250 |
D/D |
2,000 |
22,788 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2006-08-15 |
4 |
OE |
$9.88 |
$19,750 |
D/D |
2,000 |
23,788 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2006-07-17 |
4 |
OE |
$9.88 |
$20,651 |
D/D |
2,000 |
23,521 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2006-09-15 |
4 |
OE |
$9.88 |
$20,904 |
D/D |
2,000 |
23,517 |
0 |
- |
|
FBRX |
Forte Biosciences Inc |
EVP & Chief Financial Officer |
|
2017-12-08 |
4 |
A |
$8.50 |
$21,250 |
D/D |
2,500 |
7,500 |
0 |
- |
|
FBRX |
Forte Biosciences Inc |
EVP & Chief Financial Officer |
|
2019-05-28 |
4 |
B |
$4.30 |
$21,475 |
D/D |
5,000 |
15,042 |
2.74 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2006-03-15 |
4 |
OE |
$5.73 |
$22,929 |
D/D |
2,500 |
27,690 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2006-05-15 |
4 |
OE |
$9.63 |
$23,735 |
D/D |
2,000 |
22,897 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2005-10-05 |
4 |
D |
$35.56 |
$25,034 |
D/D |
(704) |
26,498 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2005-10-05 |
4 |
OE |
$5.73 |
$25,069 |
D/D |
4,375 |
27,202 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP & Chief Financial Officer |
|
2004-09-02 |
4 |
D |
$21.87 |
$26,222 |
D/D |
(1,199) |
19,262 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP & Chief Financial Officer |
|
2004-09-02 |
4 |
OE |
$5.73 |
$26,256 |
D/D |
2,930 |
19,429 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2006-06-15 |
4 |
OE |
$13.25 |
$26,500 |
D/D |
2,000 |
23,788 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2006-10-31 |
4 |
OE |
$11.13 |
$27,813 |
D/D |
2,500 |
25,094 |
0 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2024-02-29 |
4 |
B |
$56.90 |
$28,450 |
D/D |
500 |
8,573 |
2.39 |
% |
|
144 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|